Dr. Wang was one of 3 recipients of the 2024 ACS Infectious Diseases Young Investigator Award

The award honors the recipients’ contributions to the field of infectious diseases research at an early stage in their careers. Read article here.

Dr. Wang also published a paper in Science reporting the discovery of oral SARS-CoV-2 antiviral drug candidates targeting the viral papain-like protease. See below links.